EP4086264
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.5.2016EP published:
25.10.2023EP application number:
22166479.0
EPO information:
European Patent Register
Max expiry date:
17.5.2036
Title in English:
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITYLanguage of the patent:
English
Timeline
Today
18.5.2016EP application
25.10.2023EP Publication
Owner
Name:
Sumitomo Pharma Oncology, Inc.Address:
84 Waterford Drive, Marlborough, MA 01752, US
Inventor
Name:
Siddiqui-Jain, AdamAddress:
South Jordan, UT 84095, US
Name:
Bearss, David J.Address:
Alpine, UT 84004, US
Priority
Number:
201562163188 PDate:
18.5.2015Country:
US
Classification
Categories:
C07F 9/12, A61K 31/661, A61P 35/00